We attempted to purify a substance that inhibits mitogen-induced proliferation of murine splenic T-lymphocytes from Salmonella rtphinzurium.
Introduction
Sdmnnella ~vphii71urium is a facultative intracellular pathogen that causes systemic infection in mice [I] . The host defence in murine salmonellosis. a model system of human typhoid fever, involves both humoral and cellular immune responses [2, 3] . Immunization with a sublethal dose of viable bacterial cells induces high levels of protection against virulent strains. although recent studies have demonstrated that such Salmonella-immunized mice show signs of profound immunosuppression, which is reflected by a greatly reduced ability of their spleen cells to respond to a variety of B-and T-cell mitogens 14-71. Previously. we demonstrated that the immunosuppression of T-cells in Sulmonella-infected mice involved inhibition of responsiveness to interleukin-2 (IL-2) [8] and augmentation of IL-2 receptor a-chain (IL-2R cy ) expression [9] . Furthermore, similar phenomena were observed in in vitro experiments using a cell-free extract (soluble fraction) of S. ephilnuriun? [ 10, I I] . These findings indicate that the immunosuppression induced by S. Qphimuriutn infection may be regulated by a product from the bacterial cells. However, the detailed mechanism(s) responsible for the immunosuppression is/are not fully understood. In this study. therefore, we attempted to isolate the product from S. ryphiw1uriun7 with the ability to inhibit mitogen-in-092X-8143/96/$15.00 C 1996 Federalion of European Microbiological Societies. All rights rescr\sed .sSD/ 0928-8234~95)00117-1 duced proliferation of murine splenic T-lymphocytes and to clarify its effects on T-cells.
Materials and methods

I. Pur~ficutinn of un inhibitor of T-cell proliferation
The activity of the target substance was monitored by measuring its ability to inhibit phytohemagglutinin (PHAI-induced proliferation of murine splenic T-lymphocytes.
The protein concentration of each sample was monitored by measuring the AzxO or with the Bio-Rad protein assay system (Nippon BioRad Laboratories, Tokyo). The bacteria (S. ephimurium LT2) were grown on L-agar for 18 h at 37°C harvested and then suspended in phosphatebuffered saline (PBS, pH 7.2). The whole-cell protein filtrate (filter size, 0.22 pm) of bacterial cell (wet weight: 320 mg> ultrasonicates (Kubota INS 200 M; 9 kHz. 200 W, 20 min, 4°C) was collected and separated by ultracentrifugation (150.000 X g for 30 min at 4°C) to yield soluble (cytosolic) and insoluble (membrane) fractions. The protein concentration of the soluble fraction was adjusted to 1 mg/ml with 10 mM phosphate-buffer (pH 7.5) and 20 ml was applied to a Mono Q HR 5/5 (Pharmacia LKB Biotechnology, Tokyo) column (0.5 cm by 5 cm) equilibrated with 10 mM phosphate-buffer (pH 7.5). which was eluted with a linear gradient of 0 to 0.2 M NaCl in this buffer using a Pharmacia FPLC system. The most active fraction (1 ml) was chromatographed on a Superdex 200 HR lo/30 (Pharmacia LKB Biotechnology) column (1 cm by 30 cm) equilibrated with PBS (pH 7.2). The most active fractions (2 ml> from this procedure were concentrated S-fold with a Centricon-(Grace Japan KKAmicon, Tokyo) and chromatographed on a HiLoad 16/60 Superdex 75 p.g. (Pharmacia LKB Biotechnology) column (1.6 cm by 60 cm> equilibrated with PBS (pH 7.2). and the fraction (I ml) with the highest activity was concentrated IO-fold with a Centriconand defined as the purified product.
Tissue culture medium utzd reugents
The tissue culture medium comprised RPM1 1640 (Nissui, Tokyo) supplemented with 10% (v/v) fetal calf serum (FCS; HyClone Laboratories, Logan, UT), 2 mM glutamine (Nissui), 10 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPESI buffer (Sigma Chemical Co.. St. Louis, MO), penicillin (100 U/ml: Gibco. Grand Island. NY) and streptomycin (100 Fg/ml; Gibco). The mitogenic lectin used was phytohemagglutinin (PHA; Burroughs-Wellcome.
Greenville, NC) and the Rphycoerythrin-conjugated rat anti-mouse IL-2 receptor a-chain (CD251 monoclonal antibody was purchased from PharMingen, San Diego, CA. All the other reagents and chemicals used were of reagent grade or the highest grade available commercially.
Spleen cells (4 X 10' in a volume of 0.2 ml> from 6-g-week-old male BALB/c mice were added to triplicate wells of 96-well flat-bottomed tissue culture plates (Costar. Cambridge, MA). incubated with 2 pg/ml PHA at 37°C for 48 h in 5% (v/v> CO? and 95% (v/v> air and then pulsed with 0.5 &i [ 'Hlthymidine (2.0 Ci/mmol; DuPont. Wilmington, DE) for 18 h. The cells were harvested on glass fiber filters (Skatron. Sterling, VA) and the amount of radioactivity incorporated was determined by liquid scintillation counting.
Heat cmd en,-?'tne treatment
The purified product (20 pg/ml) was digested at 37°C for 2 h with trypsin (20 pg/ml, Sigma), RNase type A (2 Kg/ml. Sigma), N-glycosidase F (0.2 U/ml, Boehringer Mannheim. Germany) or heated at 80°C for 30 min.
Flow-cytometric armlysis
The expression of IL-2R was monitored by measuring the immunofluorescence using a monoclonal anti-IL-2Rcu (CD25) antibody. Murine splenic Tcells (1 X 10h cells per staining) were incubated on ice for 30 min with R-phycoerythrin-conjugated monoclonal rat anti-mouse CD25 antibody, washed twice with PBS and the stained cells were resuspended in 1% (w/v> paraformaldehyde in PBS to fix the cells for subsequent flow-cytometric (FACS) analysis, which was carried out on all the cell preparations using a FACSort (Becton Dickinson). 
Statistics
The data were expressed as means + S.E.M. and differences between them were analyzed using Student's t-test with a two-tailed test of significance [ 121. Differences at P < 0.05 were considered to be significant. The fraction with the highest activity (tube no. I5 and 16. pooled) was concentrated 5-fold and subjected to chromatography applied on a HiLoad Superdex 75 p.g. column. 3. Results and discussion 3.1. Put$cution of a substance inhibiting mitogeninduced T-cell prol(feration Previously. we observed that the active substance was present in the soluble (cytosolic) fraction of the whole-bacterial cell protein [IO] . First, therefore, the bacterial cellular soluble fraction was chromatographed on a Mono Q column, which yielded several protein peaks. The substance with the highest activity was eluted in the first protein peak, corresponding to a position of 65 mM NaCl (Fig. I) , and this fraction (tube number I I) was chromatographed on a Superdex 200 HR column, which yielded several protein peaks. The active substance was eluted in the first large peak (Fig. 2) and collected in tubes I5 and 16. Finally, these fractions were pooled, concentrated 5-fold and chromatographed on a HiLoad Superdex 75 p.g. column, which yielded several protein peaks. The active substance was eluted only in the first peak and corresponded to a molecular mass of 90 kDa (Fig. 3) . Analysis by SDS-PAGE of the peak fraction revealed that the active fraction migrated as a single band corresponding to a molecular mass of 87 kDa (Fig. 4) Fraction number (1 ml/tube) Fig. 3 . HiLoad Superdex 75 p.g. chromatographic elution profile. The pooled sample shown in Fig. 2 (88 kg protein in 0.4 ml) was chromatographed on a HiLoad Superdex 75 p.g. column (1.6 cm by 60 cm) equilibrated with PBS (pH 7.2) and eluted with PBS at a flow rate of 0.5 ml/min.
The fraction (1 ml) with the highest activity was concentrated IO-fold and defined as the purified product. 'I One unit is defined ah the sample dilution at which half-maximal inhibition of the mitogen-induced proliferative response of murine spleen cells was attained. Murine spleen cells (4X IOF per well) were incubated with 2 Kg/ml PHA and samples at various dilutions for 66 h. after which the proliferative response was examined. The half-maximal dilution value was obtained from the titration curve (plot of log [dilution] versus the counts per minute obtained). h Specific activity (U/mg protein).
designated the purified substance S. gphimurium-derived inhibitor of T cell proliferation (STI). Typical results obtained during the entire sequential ST1 purification procedure are summarized in Table 1 . When calculated on the basis of specific activity, the ST1 obtained after the last purification step was purified 45fold from the whole-cell protein.
Biological actil,ity of STI
Initially, the ability of ST1 to inhibit mitogen-induced proliferation of murine splenic T-lymphocytes was examined. Murine spleen cells were incubated in vitro with 2 Fg/ml PHA and various concentrations of ST1 for 66 h and the [ 'Hlthymidine uptake was determined. The minimum concentration that exerted an inhibitory effect was 0.2 pg/ml and maximal inhibition was achieved with 1 Fg/ml (Fig. 5) . The inhibitor had no inhibitory effect after heating (80°C. 30 min) or digestion with trypsin. but was resistant to RNase and glycosidase (data not shown).
Next, the ability of ST1 to augment IL-2Ra expression on mitogen-stimulated splenic lymphocytes was examined. Previously. we observed that the inhibition of T-cell proliferation induced by Sal~nonelln infection or Su/rnone/la cell-free extract was associated with augmentation of IL-2Ra expression on PHA-stimulated spleen cells [9,1 11. Murine spleen cells were incubated in vitro with 2 pg/ml PHA and 0.5 Kg/ml ST1 for 48 h and then stained with antiXD2S antibody. Representative reLog Fluorescence sults from a single mouse demonstrated that treatment with ST1 augmented IL-2Ra expression on PHA-stimulated splenic lymphocytes and the expression was restored to normal levels by the addition of 5 pg/ml anti-IFN-y antibody (Fig. 6) . These results indicate that ST1 has the ability to augment IL-2Ra expression and this property is regulated by excess IFN-y secretion. Our recent study demonstrated that ST1 augmented IFN-?/ production from the activated T-cell (data not shown). Therefore, the inhibition of T-cell proliferation induced by ST1 could be explained by the results of previous studies [ 13, 141 which demonstrated a suppressive effect of IFN on T-cell proliferation and a role of IFN-7 in up-regulation of IL-2R a expression. Absorption of secreted IL-2 due to surplus IL-2Ra expression on T-cells may result in the suppression of T-cell proliferation, because of a decrease in the association between IL-2 and functional IL-2R (high affinity IL-2R).
The results of our present study demonstrate that S. typlzimurium produces a novel protein (STI) with the ability to inhibit mitogen-induced proliferation of murine splenic T-lymphocytes.
Furthermore. this protein augmented IL-2Rcr expression on PHAstimulated splenic lymphocytes via an IFN-7 mediated mechanism. These phenomena correlated with each other and also have been observed in Snlmonella-infected mice [9] . Therefore, the immunosuppression induced by Salmonella infection may be attributable to STI. Studies to clarify the in vivo role of this protein in T-cell suppression and the target cells involved are currently under way.
